[1] Greenberg JA, Hsu J, Bawazeer M, Marshall J, et al. Clinical practice guideline: management of acute pancreatitis. Can J Surg, 2016, 59:128-140.
[2] 徐毅晖, 陈垦, 崔淑兰, 等. 促炎和抗炎因子在急性胰腺炎发病机制中的研究进展. 世界华人消化杂志, 2010, 18:1912-1918.
[3] Chen T, Ye X, Huang Z, Chen R, et al. Fgl2 prothrombinase is involved in severe acute pancreatitis-associated liver injury. Hepatogastroenterology, 2012, 59:1225-1229.
[4] 金雯彦, 于 锋. 异甘草酸镁防治药物性肝损伤的药理及临床研究进展. 药学进展, 2013, 37:161-166.
[5] 王峰. 异甘草酸镁在大鼠胰腺炎肝损害治疗中的作用. 中国药物与临床, 2014, 14:180-182.
[6] 中华医学会外科学分会胰腺外科学组. 急性胰腺炎诊治指南(2014). 中国实用外科杂志, 2015, 35:4-7.
[7] 徐彦哲, 丁佑铭, 汪斌, 等. 急性胰腺炎肝损伤的研究进展. 中华肝胆外科杂志, 2015, 21:284-288.
[8] Xu Q, Wang J, Chen F, et al. Protective role of magnesium isoglycyrrhizinate in non-alcoholic fatty liver disease and the associated molecular mechanisms. Int J Mol Med, 2016, 38:275-282.
[9] 赵建, 刘红辉, 谭波宇. 异甘草酸镁对重症急性胰腺炎肝损伤治疗作用的实验研究. 医学研究杂志, 2014, 43:147-149.
[10] 颜琼, 邓明明. 核因子-κB在重症急性胰腺炎肝损伤中的作用. 广东医学, 2014, 35:614-616.
[11] Kim MJ, Bae GS, Jo IJ, et al. Loganin protects against pancreatitis by inhibiting NF-κB activation. Eur J Pharmacol, 2015, 765:541-550.
[12] Tang GH, Yang HY, Zhang JC, et al. Magnesium isoglycyrrhizinate inhibits inflammatory response through STAT3 pathway to protect remnant liver function. World J Gastroenterol, 2015, 21:12370-12380.
[13] 陈胜全, 杨全德, 王绪山, 等. 异甘草酸镁治疗急性胰腺炎的临床研究. 重庆医学, 2015, 44:3985-3987. |
